Lindome, Sweden

Karl-Erik L Falk

This inventor holds 2 USPTO granted patents. Top assignee: Aktiebolaget Hassle. Active years: 1987-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl-Erik L Falk. Retrieved from https://idiyas.com/inventor/karl-erik-l-falk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 1987-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Karl-Erik L Falk

Introduction

Karl-Erik L Falk is a notable inventor based in Lindome, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. With a total of 2 patents, his work focuses on enhancing the efficacy and delivery of pharmaceutical compounds.

Latest Patents

Falk's latest patents include innovative solutions for drug release and preparation. One of his patents is for "New pharmaceutical preparations with extended release." This invention involves an extended release preparation of an active compound with very low solubility, which contains the active compound dissolved or dispersed in a semi-solid or liquid non-ionic solubilizer. The amount by weight of the solubilizer is at least equal to the amount by weight of the active compound, along with a process for its preparation.

Another significant patent is the "Drug release device." This device is designed for inclusion in a parenteral drug delivery system. It comprises a chamber with an inlet for a liquid that can be administered to a patient by a parenteral route. The device features a drug dissolution space within the chamber, allowing the liquid to flow through, and an outlet for the liquid. It also includes means for receiving and retaining a drug preparation from which a drug can be released into the liquid during parenteral delivery. This device is characterized by having one or more drug release cells that initially isolate the drug preparation from the liquid, with mechanisms for emptying the contents into the drug dissolution space after insertion.

Career Highlights

Karl-Erik L Falk is associated with Aktiebolaget Hassle, where he has been instrumental in developing innovative pharmaceutical solutions. His work has contributed to advancements in drug delivery systems, making medications more effective and accessible.

Collaborations

Falk has collaborated with notable colleagues, including Bengt G Berglund and Dan A Magnusson. Their combined expertise has fostered a productive environment for innovation in the pharmaceutical industry.

Conclusion

Karl-Erik L Falk's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the challenges in the field and a dedication to finding effective solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…